FSH, LH and Testosterone in Male Infertility: Reading the Results Together

Abnormal semen parameters should be interpreted using proper sample collection, laboratory methods and often a repeat test when indicated. Abstinence interval, illness, collection problems and ordinary variability matter. An andrologist or reproductive urologist combines the report with medical history, medication use, reproductive history and a focused examination. Hormone testing is most informative when there are findings such as substantial oligospermia, azoospermia, low libido or signs of androgen deficiency.

FSH participates in regulating sperm production. A higher result may be consistent with impaired testicular sperm production, but it does not prove that no usable sperm exist. A normal FSH does not exclude a sperm problem or distinguish every obstruction. The interpretation must include testicular size, semen volume, other hormones and examination findings. A single FSH number cannot predict the outcome of surgical sperm retrieval or guarantee natural conception.

Low testosterone can coexist with fertility concerns, but not all causes are the same. LH helps the specialist evaluate how the testes are being stimulated. Exogenous testosterone or anabolic steroids can suppress sperm production, making medication history crucial. Someone planning a pregnancy should never start testosterone replacement from a non-fertility consultation without discussing reproductive goals. The correct response to a low result is specialist evaluation, not buying unverified “testosterone booster” supplements.

Inline infographic COMPONENT SPEC — Article 08

• Component name: FertilityEvidenceSteps; render accessible native HTML/CSS, not a fixed or AI-generated raster image.
• Headline: When male hormone testing is useful: six practical decisions.
• Design: six sequential numbered cards, clear labels, minimal iconography, neutral colours and no numeric success claims or prices.
• Cards / steps: 1. Start with a reliable semen assessment — icon: clipboard-list; microcopy: Abnormal semen parameters should be interpreted using proper sample collection, laboratory methods and often a repeat test when indicated. 2. What FSH can—and cannot—tell you — icon: microscope; microcopy: FSH participates in regulating sperm production. 3. Testosterone and LH need context — icon: stethoscope; microcopy: Low testosterone can coexist with fertility concerns, but not all causes are the same. 4. Azoospermia changes the investigation — icon: calendar-check; microcopy: If no sperm are seen, the laboratory may need to examine the centrifuged specimen and the clinician may investigate obstructive versus non-obstructive causes. 5. Coordinate the couple rather than split the problem — icon: shield-check; microcopy: Both partners may need parallel assessment to avoid delaying care. 6. Facility boundary and next action — icon: hospital; microcopy: Where actually available, discuss suitable home blood collection or remote review; required scans and IVF laboratory and transfer procedures stay in a facility.
• Accessibility alt / accessible label: Six-step guide to when male hormone testing is useful: Start with a reliable semen assessment; What FSH can—and cannot—tell you; Testosterone and LH need context; Azoospermia changes the investigation; Coordinate the couple rather than split the problem; in-clinic procedures and verified home support.
• Mobile layout: single column at ≤640px, card sequence maintained; 2 columns on tablets and 3 on wide screens; keyboard-readable, semantic headings and high contrast; icons decorative with aria-hidden=true.
• Data policy: no illustrative survival rates, percentages, prices, patient counts or invented locations; keep factual statements aligned with clinician-approved article.

If no sperm are seen, the laboratory may need to examine the centrifuged specimen and the clinician may investigate obstructive versus non-obstructive causes. Genetic testing is appropriate in selected severe male-factor cases under guideline criteria. Surgery, sperm retrieval and ICSI are distinct steps with different indications. A hormone test alone does not justify any of them. Ask what the diagnosis is, what findings support it and whether further tests could actually change treatment.

Both partners may need parallel assessment to avoid delaying care. A clinician can discuss whether IUI is realistic or whether laboratory-assisted fertilisation should be considered if sperm parameters are severely affected. Some blood tests may be collected remotely when available and medically suitable, but semen laboratory processing and any surgical retrieval remain facility-based. A practical plan sets out which doctor owns the male-factor investigation and how results will be shared with the fertility team.

The relevant question in when male hormone testing is useful is how this finding changes the next clinical decision. A clinician should consider age, symptoms, medical history, partner factors when relevant, prior pregnancy history and the outcome of any previous treatment. A test may be valuable when it would actually change management; repeating it just because an online list recommends it may waste time. Different diagnoses can produce similar search terms, so do not treat a generic success claim or a stranger’s laboratory value as your own prognosis.

For HomeIVF, “at home” refers only to the parts of a clinician-led fertility pathway that are safe to organise outside the clinic. Some teleconsultations, suitable blood samples or prescribed-injection assistance may be possible after operational confirmation. Availability cannot be inferred from a city name or an online page. Ultrasound monitoring when indicated, sperm preparation, intrauterine insemination, retrieval of eggs, embryology, biopsy and transfer of embryos need licensed or appropriately equipped clinical and laboratory facilities. An individualized appointment calendar matters more than any generic promise about few visits.

Request a written distinction between necessary tests, optional investigations and interventions supported by limited evidence. Ask who interprets each result and at what point treatment could change. A fertility pathway can include costs outside the headline package: monitoring, medicines, anaesthesia, laboratory procedures, storage, and later transfers may be billed separately. The right estimate is an itemized, patient-specific quote. Neither internet prices nor an apparently discounted package establish how much your own treatment will cost.

Ask the clinician to explain: (1) which finding is documented, (2) what decision depends on it, (3) what alternatives are available, and (4) what potential risks, costs or uncertainties remain. For when male hormone testing is useful, request an answer specific to the actual record, not a standard package. If a different doctor has proposed another approach, compare the reasons and the evidence rather than counting how many tests or medicines each suggests. Written decisions can also help plan any necessary clinic attendance.

Medication doses, procedural timing and test interpretation belong to the responsible clinician. New severe pain, heavy bleeding, collapse, marked swelling or breathing difficulty should trigger urgent medical attention, not a scheduled teleconsultation. A normal-looking earlier report cannot rule out a new complication.